Cell Death and Survival |
Apoptosis |
0.000115 |
STAT4, DLL1, TLN1, IFNAR2, GFRA1, IL6R, CDC37, SH3RF1, AFP, RRM2B, USP53 |
11 |
Cell Death and Survival, Organismal Injury and Abnormalities |
Necrosis |
0.000173 |
STAT4, DLL1, TLN1, IFNAR2, GFRA1, IL6R, CDC37, SH3RF1, AFP, RRM2B, USP53 |
11 |
Cell-To-Cell Signalling and Interaction |
Activation of lymphatic system cells |
0.000192 |
DLL1, STAT4, TLN1, IL6R, AFP |
5 |
Tissue Morphology |
Quantity of cells |
0.000288 |
STAT4, DLL1, TLN1, IFNAR2, GFRA1, IL6R, SHC2, AFP, KALRN |
9 |
Cell Death and Survival, Organismal Injury and Abnormalities |
Cell death of tumor cell lines |
0.000662 |
DLL1, TLN1, IFNAR2, IL6R, CDC37, SH3RF1, AFP, RRM2B |
8 |
Cell Death and Survival, Organismal Injury and Abnormalities |
Cell death of immune cells |
0.000773 |
DLL1, STAT4, TLN1, IL6R, AFP |
5 |
Cellular Movement |
Migration of cells |
0.0038 |
DLL1, TLN1, GFRA1, IL6R, PARP9, SH3RF1, EPB41L5, KALRN |
8 |
Nervous System Development and Function |
Morphology of nervous system |
0.00591 |
GFRA1, IL6R, SHC2, RRM2B, KALRN |
5 |
Cell Morphology, Nervous System Development and Function, Tissue Morphology |
Morphology of neurons |
0.00604 |
GFRA1, IL6R, SHC2, KALRN |
4 |
Neurological Disease, Organismal Injury and Abnormalities |
Progressive neurological disorder |
0.0116 |
DLL1, IFNAR2, IL6R, RRM2B, USP53 |
5 |
Cancer, Organismal Injury and Abnormalities |
Carcinoma |
0.0142 |
STAT4, TLN1, IFNAR2, GFRA1, IL6R, SHC2, PARP9, EIF1AD, CDC37, SH3RF1, AFP, RRM2B, DLL1, EPB41L5, PSKH1, KALRN, GRB14, USP53 |
18 |